About Us

"After chemo I can't eat, can't sleep, I'm exhausted and losing my hair—isn't there a gentler way?" This is what I hear most from breast cancer patients in the clinic. According to the latest China Cancer Registry data, over 420,000 new breast cancer cases are reported each year, and more than 70% of patients experience nausea, low immunity, and anxiety about recurrence during or after chemo and radiation. TCM breast cancer treatment, with its focus on "treating both root and branch, supporting the healthy and dispelling the pathogenic," has become a vital support for many on the road to recovery.

"Doctor, I only had an occasional cough—how could it be mid-stage lung cancer?" This is the question I hear most in 30 years of practice. WHO reports over 2.2 million new lung cancer cases globally each year; China accounts for nearly 30%, and about 80% of patients are diagnosed at an advanced stage, with a 5-year survival of only 19.7%. The main reason is that many people lack awareness of lung cancer symptoms and mistake early signs for a cold or bronchitis, delaying care.

"Doctor, I just had some fatigue and didn't feel like eating—how can it be advanced liver cancer?" This is what I hear most in 30 years in the liver clinic. WHO reports about 900,000 new liver cancer cases globally each year; China accounts for about 47%, the highest worldwide. About 80% of patients are diagnosed at an advanced stage, with 5-year survival under 15%, while early liver cancer with proper treatment can reach over 70% 5-year survival.

"The doctor said the gastric cancer is already advanced and chemotherapy isn't working well—is there any other option?" This is the question many patients and families ask. As one of the most common digestive tract cancers, gastric cancer has a guarded prognosis, especially when locally advanced or metastatic. Immunotherapy has brought new hope; Keytruda (pembrolizumab), a PD-1 inhibitor, is a major advance in gastric cancer treatment.

"Mesothelioma is diagnosed, chemotherapy isn't working—is there any other option?" Mesothelioma is a rare, aggressive cancer often linked to asbestos; advanced median survival is about 1 year and traditional chemo is limited. Verzenio (abemaciclib), a CDK4/6 inhibitor, has shown promise in trials for p16ink4a-negative, post-chemo mesothelioma, offering new hope for advanced patients.

"Multiple myeloma is diagnosed, chemo isn't working well, and we're worried about resistance—are there any new options?" MM is common in ages 55–65; China sees about 35,000–40,000 new cases yearly. Kisqali (ribociclib), a CDK4/6 inhibitor, is approved for breast cancer but has shown potential in relapsed/refractory MM, offering new hope for some patients.

"After a cancer diagnosis, besides chemo and radiation—can TCM help?" "Will Chinese herbs conflict with Western drugs?" China sees over 4.5 million new cancer cases yearly; more people are turning to TCM alongside Western treatment. TCM cancer care centers on "supporting healthy qi and dispelling pathogenic factors" and "treating both root and branch"—to reduce suffering, lower relapse risk, and improve quality of life. This guide covers principles, methods, when to use TCM, common myths, and FAQ.

"Doctor, I keep seeing blood in my stool—is it bowel cancer?" "I heard colonoscopy is very painful—can I skip it?" Colorectal cancer is China's 2nd most common and 3rd deadliest cancer; over 560,000 new cases and 280,000 deaths yearly, with nearly 60% diagnosed at mid-to-advanced stage. Colorectal cancer is the only major cancer that can be made "preventable and treatable" through screening—colonoscopy is the gold standard. This guide helps you overcome myths and protect your bowel health.

"I wasn't scared at diagnosis, but in recovery I wake up lost every day—what to eat, what to do, afraid one wrong step will undo everything." Over 4 million patients enter cancer recovery yearly in China; only 23.7% stick to science-based rehab—those who keep a daily check-in have 51.3% lower relapse than irregular management. Daily check-in uses regular logging and action to reduce rehab risks and strengthen outcomes. This guide covers why to check in, what to track, how to do it, and FAQ.